“Poorly differentiated” refers to cancer cells that have more abnormalities and look less like normal cancer cells. Poorly differentiated thyroid cancer is uncommon, accounting for fewer than 5% of ...

Thyroid Cancer Stem Cells as an Attractive Target for Therapy of Poorly Differentiated Thyroid Carcinomas Despite the overall low mortality rate of thyroid cancer, poorly differentiated thyroid ...

If a doctor has diagnosed you with thyroid cancer, the next step in your cancer journey may be treatment. What are your treatment options, and how do doctors decide which one might be best for you?

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

consisting of partial responses in two of six patients with oncocytic subtype and one of five with poorly differentiated ...

The case comes from a phase 1 study of its ICAM-1 targeting CAR-T autologous candidate AIC100 in patients with relapsed/refractory poorly differentiated thyroid cancer (PDTC) and anaplastic ...

Francis P. Worden, MD, discusses how the effectiveness of lenvatinib in this real-world setting compares with results from ...

A type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results of a clinical trial published in JAMA Oncology.

Surgery and radioiodine therapy are usually effective for most patients with differentiated thyroid cancer. However, poorly differentiated and anaplastic thyroid carcinomas represent a challenge ...